Injection device and cap for injection device
Latest Sanofi-Aventis Deutschland GMBH Patents:
- Drive mechanisms suitable for use in drug delivery devices
- USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTERS
- Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
- Processes for the preparation of (R)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
- THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTER
Description
Claims
The ornamental design for an injection device and cap for injection device, substantially as shown and described.
Referenced Cited
U.S. Patent Documents
| 6575939 | June 10, 2003 | Brunel |
| D545364 | June 26, 2007 | Ternovits |
| D650857 | December 20, 2011 | Lira-Nunez |
| D697205 | January 7, 2014 | Schneider |
| D708317 | July 1, 2014 | Schneider |
| D731051 | June 2, 2015 | Olson |
| D732161 | June 16, 2015 | Ohashi |
| D757255 | May 24, 2016 | Wohlfahrt |
| D758567 | June 7, 2016 | Wohlfahrt |
| D758569 | June 7, 2016 | Wohlfahrt |
| D773648 | December 6, 2016 | Wohlfahrt |
| D789528 | June 13, 2017 | Wohlfahrt |
| D793547 | August 1, 2017 | Burkett |
Patent History
Patent number: D861859
Type: Grant
Filed: Mar 2, 2017
Date of Patent: Oct 1, 2019
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/595,799
Type: Grant
Filed: Mar 2, 2017
Date of Patent: Oct 1, 2019
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/595,799
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)